Angiogenesis, lymphangiogenesis, and melanoma metastasis

Oncogene

Volumn 22, Issue 20, 2003, Pages 3172-3179

  Streit, Michael ^a   Detmar, Michael ^b  

^a BAYER AG   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

FGF; LYVE 1; VEGF; VEGF C

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; FUMAGILLOL CHLOROACETYLCARBAMATE; INTERLEUKIN 8; MONOCLONAL ANTIBODY LM 609; TEMOZOLOMIDE; THALIDOMIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN D;

ANGIOGENESIS; BLOOD VESSEL; CELL GROWTH; CELL STIMULATION; CELL TRANSPLANTATION; CHEEK; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE MODEL; HAMSTER; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MELANOMA; METASTASIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; TREATMENT PLANNING; TUMOR GROWTH; XENOGRAFT;

ANGIOGENESIS INHIBITORS; ANIMALS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTORS; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPH NODES; LYMPHOKINES; MELANOMA; MELANOMA, EXPERIMENTAL; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTORS;

CRICETINAE;

EID: 0038456130     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206457     Document Type: Review

References (111)

1. Achen MG, Williams RA, Minekus MP, Thornton GE, Stenvers K, Rogers PA, Lederman F, Roufail S and Stacker SA. (2001). J. Pathol., 193, 147-154.
2. Ahmed NU, Ueda M, Ito A, Ohashi A, Funasaka Y and Ichihashi M. (1997). Melanoma Res., 7, 299-305.
3. Barnhill RL, Fandrey K, Levy MA, Mihm Jr MC and Hyman B. (1992). Lab. Invest., 67, 331-337.
4. Barnhill RL and Levy MA. (1993). Am. J. Pathol., 143, 99-104.
5. Barnhill RL, Xiao M, Graves D and Antoniades HN. (1996). Br. J. Dermatol., 135, 898-904.
6. Bayer-Garner IB, Hough Jr AJ and Smoller BR. (1999). Mod. Pathol., 12, 770-774.
7. Becker D, Lee PL, Rodeck U and Herlyn M. (1992). Oncogene, 7, 2303-2313.
8. Becker D, Meier CB and Herlyn M. (1989). EMBO J., 8, 3685-3691.
9. Bhargava P, Marshall JL, Rizvi N, Dahut W, Yoe J, Figuera M, Phipps K, Ong VS, Kato A and Hawkins MJ. (1999). Clin. Cancer Res., 5, 1989-1995.
10. Boehm T, Folkman J, Browder T and O'Reilly MS. (1997). Nature, 390, 404-407.
11. Buerkle MA, Pahernik SA, Sutter A, Jonczyk A, Messmer K, Dellian M. (2002). Br. J. Cancer., 86, 788-795.
12. Busam KJ, Berwick M, Blessing K, Fandrey K, Kang S, Karaoli T, Fine J, Cochran AJ, White WL, Rivers J. (1995). Am. J. Pathol., 147, 1049-1056.
13. Carmeliet P and Jain RK. (2000). Nature, 407, 249-257.
14. Carnochan P, Briggs JC, Westbury G and Davies AJ. (1991). Br. J. Cancer, 64, 102-107.
15. Cascinelli N, Herlyn M, Schneeberger A, Kuwert C, Slominski A, Armstrong C, Belli F, Lukiewcz S, Maurer D, Ansel J, Stingl G and Saida T. (2000). Exp. Dermatol., 9, 439-451.
16. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo K-T, Manseau EJ and Dvorak HF. (1996). Cancer Res., 56, 172-181.
17. Dadras SS, Paul T, Bertoncini J, Brown LF, Mucikansky A, Jackson DG, Ellwanger U, Garbe C, Mihm MC, Detmar M. (2003). Am. J. Pathol., in press.
18. Detmar M. (1996). J. Invest. Dermatol., 106, 207-208.
19. Detmar M and Hirakawa S. (2002). J. Exp. Med., 196, 713-718.
20. Dotto GP, Moellmann G, Ghosh S, Edwards M and Halaban R. (1989). J. Cell. Biol., 109, 3115-3128.
21. Dreau D, Foster M, Hogg M, Swiggett J, Holder WD and White RL. (2001). Oncol. Res., 12, 241-251.
22. Dvorak HF, Brown LF, Detmar M and Dvorak AM. (1995). Am. J. Pathol., 146, 1029-1039.
23. Eisen T, Boshoff C, Mak I, Sapunar F, Vaughan MM, Pyle L, Johnston SR, Ahern R, Smith IE, Gore ME (2000). Br. J. Cancer, 82, 812-817.
24. Erhard H, Rietveld FJ, van Altena MC, Brocker EB, Ruiter DJ and de Waal RM. (1997). Melanoma Res., 7(Suppl 2), S19-S26.
25. Ferrara N. (1999). Curr. Top. Microbiol. Immunol., 237, 1-30.
26. Ferrara N and Alitalo K. (1999). Nat. Med., 5, 1359-1364.
27. Folkman J. (1975). Ann. Intern. Med., 82, 96-100.
28. Folkman J. (2002). Cancer Cell, 1, 113-115.
29. Forsberg K, Valyi-Nagy I, Heldin CH, Herlyn M and Westermark B. (1993). Proc. Natl. Acad. Sci. USA, 90, 393-397.
30. Gitay-Goren H, Halaban R and Neufeld G. (1993). Biochem. Biophys. Res. Commun., 190, 702-709.
31. Graeven U, Fiedler W, Karpinski S, Ergun S, Kilic N, Rodeck U, Schmiegel W and Hossfeld DK. (1999). J. Cancer Res. Clin. Oncol., 125, 621-629.
32. Graeven U, Rodeck U, Karpinski S, Jost M, Philippou S and Schmiegel W. (2001). Cancer Res., 61, 7282-7290.
33. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS and White WL. (1994). Am. J. Pathol., 145, 510-514.
34. Grant SW, Kyshtoobayeva AS, Kurosaki T, Jakowatz J and Fruehauf JP. (1998). Cancer Detect Prev., 22, 185-194.
35. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD and Williams LT. (1998). Proc. Natl. Acad. Sci. USA, 95, 258-263.
36. Hanahan D and Folkman J. (1996). Cell, 86, 353-364.
37. Hanahan D and Weinberg RA. (2000). Cell, 100, 57-70.
38. Hartmann A, Kunz M, Kostlin S, Gillitzer R, Toksoy A, Brocker EB and Klein CE. (1999). Cancer Res., 59, 1578-1583.
39. Hawighorst T, Oura H, Streit M, Janes L, Nguyen L, Brown LF, Jackson DG and Detmar M. (2002). 21, 7945-7956.
40. Hawighorst T, Velasco P, Streit M, Kyriakides TR, Brown LF, Bornstein P and Detmar M. (2001). EMBO J., 20, 2631-2640.
41. He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T and Alitalo K. (2002). J. Natl. Cancer Inst., 94, 819-825.
42. Hendrix MJ, Seftor RE, Seftor EA, Gruman LM, Lee LM, Nickoloff BJ, Miele L, Sheriff DD and Schatteman GC. (2002). Cancer Res., 62, 665-668.
43. Huang S, Mills L, Mian B, Tellez C, McCarty M, Yang XD, Gudas JM, Bar-Eli M. (2002). Am. J. Pathol., 161, 125-134.
44. Huang S, Xie K, Bucana CD, Ullrich SE and Bar-Eli M. (1996). Clin. Cancer Res., 2, 1969-1979.
45. Hubler Jr WR and Wolf Jr JE (1976). Cancer, 38, 187-192.
46. Hwu WJ (2000). Oncology, 14, 25-28.
47. Hwu WJ, Krown SE, Panageas KS, Menell JH, Chapman PB, Livingston PO, Williams LJ, Quinn CJ and Houghton AN. (2002). J. Clin. Oncol., 20, 2610-2615.
48. Ilmonen S, Kariniemi AL, Vlaykova T, Muhonen T, Pyrhonen S and Asko-Seljavaara S. (1999). Melanoma Res., 9, 273-278.
49. Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Yla-Herttuala S, Jaattela M and Alitalo K. (2001). Cancer Res., 61, 1786-1790.
50. Kashani-Sabet M, Sagebiel RW, Ferreira CM, Nosrati M and Miller III JR (2002). J. Clin. Oncol., 20, 1826-1831.
51. Kumar CC, Malkowski M, Yin Z, Tanghetti E, Yaremko B, Nechuta T, Varner J, Liu M, Smith EM, Neustadt B, Presta M, Armstrong L. (2001). Cancer Res., 61, 2232-2238.
52. Kusters B, Leenders WP, Wesseling P, Smits D, Verrijp K, Ruiter DJ, Peters JP, van Der Kogel AJ and de Waal RM. (2002). Cancer Res., 62, 341-345.
53. Lacal PM, Failla CM, Pagani E, Odorisio T, Schietroma C, Falcinelli S, Zambruno G and D'Atri S. (2000). J. Invest. Dermatol., 115, 1000-1007.
54. Lazar-Molnar E, Hegyesi H, Toth S and Falus A. (2000). Cytokine, 12, 547-554.
55. Li Y, Wang MN, Li H, King KD, Bassi R, Sun H, Santiago A, Hooper AT, Bohlen P, Bicklin DJ (2002). J. Exp. Med., 195, 1575-1584.
56. Lin P, Buxton JA, Acheson A, Radziejewski C, Maisonpierre PC, Yancopoulos GD, Channon KM, Hale LP, Dewhirst MW, George SE and Peters KG. (1998). Proc. Natl. Acad. Sci. USA, 95, 8829-8834.
57. Liu B, Earl HM, Baban D, Shoaibi M, Fabra A, Kerr DJ and Seymour LW, (1995). Biochem. Biophys. Res. Commun., 217, 721-727.
58. Lode HN, Moehler T, Xiang R, Jonczyk A, Gillies SD, Cheresh DA and Reisfeld RA. (1999). Proc. Natl. Acad. Sci. USA, 96, 1591-1596.
59. Luca M, Huang S, Gershenwald JE, Singh RK, Reich R and Bar-Eli M. (1997). Am. J. Pathol., 151, 1105-1113.
60. Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G and Pepper MS. (2001). EMBO J., 20, 672-682.
61. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ. (1999). Am. J. Pathol., 155, 739-752.
62. Marcoval J, Moreno A, Graells J, Vidal A, Escriba JM, Garcia RM and Fabra A. (1997). J. Cutan. Pathol., 24, 212-218.
63. Miao WM, Seng WL, Duquette M, Lawler P, Laus C and Lawler J. (2001). Cancer Res., 61, 7830-7839.
64. Mihm Jr MC, Clark Jr WH and Reed RJ. (1975). Semin. Oncol., 2, 105-118.
65. Min HY, Doyle LV, Vitt CR, Zandonella CL, Stratton TJ, Shuman MA and Rosenberg S. (1996). Cancer Res., 56, 2428-2433.
66. Morin MJ. (2000). Oncogene, 19, 6574-6583.
67. Muller A, Homey B, Soto H, Ge N, Cattron D, Buchanan ME, McClanahan T, Murphy E, Yuan W and Wagner SN. (2001). Nature, 410, 50-56.
68. Naglich JG, Jure-Kunkel M, Gupta E, Fargnoli J, Henderson AJ, Lewin AC, Talbott R, Baxter A, Bird J, Savopoulos R, Wills R, Kramer RA and Trail PA. (2001). Cancer Res., 61, 8480-8485.
69. Nesbit M, Nesbit HK, Bennett J, Andl T, Hsu MY, Dejesus E, McBrian M, Gupta AR, Eck SL and Herlyn M. (1999). Oncogene, 18, 6469-6476.
70. Nurnberg W, Tobias D, Otto F, Henz BM and Schadendorf D. (1999). J. Pathol., 189, 546-551.
71. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR and Folkman J. (1997). Cell, 88, 277-285.
72. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH and Folkman J. (1994). Cell, 79, 315-328.
73. Oliver G and Detmar M. (2002). Genes Dev., 16, 773-783.
74. Papoutsi M, Siemeister G, Weindel K, Tomarev SI, Kurz H, Schachtele C, Martiny BG, Christ B, Marme D and Wilting J. (2000). Histochem. Cell Biol., 114, 373-385.
75. Plum SM, Holaday JW, Ruiz A, Madsen JW, Fogler WE and Fortier AH. (2000). Vaccine, 19, 1294-1303.
76. Posey JA, Khazaeli MB, DelGrosso A, Saleh MN, Lin CY, Huse W and LoBuglio AF. (2001). Cancer Biother. Radiopharm., 16, 125-132.
77. Potgens AJ, Lubsen NH, van AM, Schoenmakers JG, Ruiter DJ and de WR. (1995). Am. J. Pathol., 146, 197-209.
78. Prevo R, Banerji S, Ferguson DJ, Clasper S and Jackson DG. (2001). J. Biol. Chem., 276, 19420-19430.
79. Rak J, Yu JL, Kerbel RS and Coomber BL. (2002). Cancer Res., 62, 1931-1934.
80. Reed JA, McNutt NS and Albino AP. (1994). Am. J. Pathol., 144, 329-336.
81. Reiher FK, Volpert OV, Jimenez B, Crawford SE, Dinney CP, Henkin J, Haviv F, Bouck NP and Campbell SC. (2002). Int. J. Cancer, 98, 682-689.
82. Rofstad EK and Halsor EF. (2000). Cancer Res., 60, 4932-4938.
83. Rofstad EK and Halsor EF. (2002). Br. J. Cancer, 86, 301-308.
84. Saeki H, Moore AM, Brown MJ and Hwang ST. (1999). J. Immunol., 162, 2472-2475.
85. Salven P, Heikkila P and Joensuu H. (1997). Br. J. Cancer, 76, 930-934.
86. Salven P, Lymboussaki A, Heikkila P, Jaaskela SH, Enholm B, Aase K, von EG, Eriksson U, Alitalo K and Joensuu H. (1998). Am. J. Pathol., 153, 103-108.
87. Seftor RE, Seftor EA, Koshikawa N, Meltzer PS, Gardner LM, Bilban M, Stetler-Stevenson WG, Quaranta V and Hendrix MJ. (2001), Cancer Res., 61, 6322-6327.
88. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS and Dvorak HF. (1983). Science, 219, 983-985.
89. Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K and Detmar M. (2001a). Am. J. Pathol., 159, 893-903.
90. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K and Detmar M. (2001b). Nat. Med., 7, 192-198.
91. Srivastava A, Laidler P, Davies RP, Horgan K and Hughes LE. (1988). Am. J. Pathol., 133, 419-423.
92. Srivastava A, Laidler P, Hughes LE, Woodcock J and Shedden EJ. (1986). Eur. J. Cancer Clin. Oncol., 22, 1205-1209.
93. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B and Kinzler KW. (2000). Science, 289, 1197-1202.
94. Stacker SA, Baldwin ME and Achen MG. (2002). FASEB J., 16, 922-934.
95. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H and Achen MG. (2001). Nat. Med., 7, 186-191.
96. Stenzinger W, Bruggen J, Macher E and Sorg C. (1983). Eur. J. Cancer Clin. Oncol., 19, 649-656.
97. Straume O and Akslen LA. (2001). Am. J. Pathol., 159, 223-235.
98. Straume O and Akslen LA. (2002). Am. J. Pathol., 160, 1009-1019.
99. Straume O, Salvesen HB and Akslen LA. (1999). Int. J. Oncol., 15, 595-599.
100. Streit M, Stephen AE, Hawighorst T, Matsuda K, Lange-Asschenfeldt B, Brown LF, Vacanti JP and Detmar M. (2002). Cancer Res., 62, 2004-2012.
101. Ugurel S, Rappl G, Tilgen W and Reinhold U. (2001). J. Clin. Oncol., 19, 577-583.
102. Vlaykova T, Laurila P, Muhonen T, Hahka-Kemppinen M, Jekunen A, Alitalo K and Pyrhonen S. (1999). Melanoma Res., 9, 59-68.
103. Warren BA and Shubik P. (1966). Lab. Invest., 15, 464-478.
104. Weninger W, Uthman A, Pammer J, Pichler A, Ballaun C, Lang IM, Plettenberg A, Bankl HC, Sturzl M and Tschachler E. (1996). Lab. Invest., 75, 647-657.
105. Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn MD, Jackson DG and Oliver G. (2002). EMBO J., 21, 1505-1513.
106. Wild R, Dhanabal M, Olson TA and Ramakrishnan S. (2000). Br. J. Cancer, 83, 1077-1083.
107. Wiley HE, Gonzalez EB, Maki W, Wu MM and Hwang ST. (2001). J. Natl. Cancer Inst., 93, 1638-1643.
108. Yayon A, Ma YS, Safran M, Klagsbrun M and Halaban R. (1997). Oncogene, 14, 2999-3009.
109. Yu JL, Rak JW, Carmeliet P, Nagy A, Kerbel RS and Coomber BL. (2001). Am. J. Pathol., 158, 1325-1334.
110. Yu JL, Rak JW, Klement G and Kerbel RS. (2002). Cancer Res., 62, 1838-1846.
111. Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N and Jain RK. (1996). Proc. Natl. Acad. Sci. USA, 93, 14765-14770.